OT
Outlook Therapeutics, Inc.
OTLK · NASDAQ
$0.67 -4.04% (-$0.03)
1M -3.50%
Market Cap $127.3M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.87
29.5% upside
Trenutna cena
$0.67
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica OTLK trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S -109.48x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
100 /100
Strong Gross margin 195.64%
Net margin 5,254.81%
Op. margin 4,783.05%
Quality
2 /100
Poor ROIC 0.00%
ROA 0.00%
Asset turnover -0.00x
Debt
0 /100
High Current ratio 0.00x
Int. coverage -236.12x
Debt/Equity N/A
Stability
72 /100
Stable Beta 0.75x
EPS volatility 21.86%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OTLK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Charles Jahr
Employees
17
Headquarters
Iselin
Prihajajoči dogodki
18 DEC.
Earnings
Upcoming earnings report